Metis Global Partners LLC Trims Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Metis Global Partners LLC trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 13.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,909 shares of the medical device company’s stock after selling 2,073 shares during the quarter. Metis Global Partners LLC’s holdings in Cooper Companies were worth $1,279,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Victory Capital Management Inc. grew its stake in Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares in the last quarter. Alecta Tjanstepension Omsesidigt bought a new position in shares of Cooper Companies during the 4th quarter worth $49,550,000. Swedbank AB increased its stake in shares of Cooper Companies by 14.0% during the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after buying an additional 200,000 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after acquiring an additional 194,118 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of COO opened at $91.65 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The stock has a fifty day moving average price of $92.63 and a 200-day moving average price of $99.59. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market cap of $18.29 billion, a PE ratio of 47.00, a P/E/G ratio of 2.25 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the business posted $0.87 EPS. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on COO shares. Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company upped their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $117.22.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.